Crescent Capital BDC, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CCAP research report →
Range $10 – $12
Price Chart
About the company
Crescent Capital BDC, Inc. functions as a Business Development Company (BDC), managing a fund dedicated to private equity, leveraged buyouts, and providing loan capital. The firm's strategy centers on making direct investments, with a specific focus on the middle market segment.
- CEO
- Jason A. Breaux
- IPO
- 2020
- Employees
- 250
- HQ
- Los Angeles, CA, US
Get TickerSpark's AI analysis on CCAP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $361.09M
- P/E
- -997.00
- Fwd P/E
- 6.51
- PEG
- 8.83
- P/S
- 2.96
- P/B
- 0.56
- EV/EBITDA
- 20.90
- Div Yield
- 15.85%
- Gross Margin
- 77.75%
- Op Margin
- 67.16%
- Net Margin
- -0.13%
- ROE
- -0.02%
- ROIC
- -0.45%
Latest fiscal year · YoY change
- Revenue
- $156.19M+9.7%
- Gross Profit
- $121.85M+45.9%
- Op Income
- $118.93M
- Net Income
- $34.51M-53.1%
- EPS
- $0.93-53.3%
- OCF Growth
- -9.7%
- FCF Growth
- -9.7%
- 52W High
- $15.18
- 52W Low
- $8.39
- 50D MA
- $9.41
- 200D MA
- $11.38
- Beta
- 0.60
- RSI (14)
- 59
- Avg Volume
- 251.93K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Crescent Capital BDC delivered modestly higher NII, kept NAV essentially stable, and announced a $50 million buyback plus a new JV to help delever and repurchase stock.· November 10, 2026
- Net investment income rose to $0.37 per share from $0.36 and covered the $0.34 base dividend.
- NAV was largely stable at $17.72 per share versus $17.82 last quarter.
- No new investments were placed on nonaccrual; nonaccruals improved slightly to 4.7% of debt investments at cost.
- Management authorized a $50 million buyback, with Sun Life separately planning up to $25 million of open-market purchases.
- A new JV seeded with about $150 million of first-lien assets is expected in Q4 2026 to reduce leverage and fund repurchases.
Third-quarter net investment income was $0.37 per share, up from $0.36 in the prior quarter, and exceeded the $0.34 base dividend. Total investment income increased by about $600,000 to $36.9 million; interest income rose about $900,000 to $35.6 million, partly offset by lower dividend income of about $900,000 from $1.2 million. Total expenses and excise tax were stable at $23.2 million. NAV per share was $17.72 versus $17.82 in the prior quarter, with $0.06 per share of net realized losses and $0.04 per share of net unrealized depreciation. The portfolio was about $1.6 billion at fair value, gross debt was about $924 million, and cash, cash equivalents, and restricted cash were about $36 million. Leverage ended at 1.42x debt/equity, or 1.36x net of balance sheet cash, versus 1.37x net in the prior quarter. The board declared a fourth-quarter dividend of $0.34 per share and the third and final special dividend of $0.03 per share, payable December 15. Management said it expects the JV and pending realizations to bring net leverage within target range by year end.
Jason Breaux said the quarter showed steady earnings and a stable NAV despite a slow sponsor-backed M&A market. His strategic emphasis was on shareholder alignment: permanent fee reductions, a new $50 million repurchase authorization, and Sun Life’s separate commitment to buy up to $25 million more of shares. He framed the planned JV as a tool to accelerate deleveraging and create capacity for buybacks, while stressing that CCAP’s direct lending strategy and underwriting discipline will not change under the broader Greeno platform.
Gerhard Lombard highlighted that NII of $0.37 per share covered the $0.34 regular dividend and that total investment income reached $36.9 million. He said expenses and excise tax held steady at $23.2 million, gross debt declined to about $924 million from $935 million, and liquidity remained sufficient with about $247 million of cash and available borrowing capacity at quarter-end. He also noted the company remains above its long-term leverage target but expects realizations and the JV to bring leverage back within range by year end.
Analysts focused heavily on the proposed JV and its implications for buybacks, leverage, and future origination pacing. Management said the JV is primarily about deleveraging CCAP and creating capacity for repurchases, not about launching a series of similar vehicles; they also said buyback pacing will be governed by a 10b5-1 plan and regulatory requirements. On the pipeline, management said the lower and core middle market LBO environment has been quiet, but they still expect sponsor liquidity needs to eventually drive more activity, with Henry Chung describing watch-list issues as company-specific and saying they are taking a long-term approach to recoveries rather than selling stressed assets quickly.
The positive case is that CCAP is still covering its base dividend with NII, NAV is holding up, and the portfolio is described as broadly performing in line with expectations. Management is taking concrete steps that could be accretive per share — a buyback authorization, Sun Life support, and a JV intended to lower leverage and fund repurchases.
The main risks are a weak LBO and M&A environment, which is limiting new originations and slowing portfolio turnover. Watch-list exposure ticked up to 16% of the portfolio at fair value, leverage remains above target, and management acknowledged that some assets and extensions may take longer to resolve in a quieter market.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 95.9%
- Shares Outstanding
- 36.85M
- Float Shares
- 35.34M
of shares held by institutions
89 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Texas County & District Retirement System | 5.00M | 0 |
| Blackstone Inc. | 4.21M | ▼ 1 |
| Fidelity National Financial, Inc. | 3.68M | ▼ 525.00K |
| Sun Life Financial Inc | 2.23M | 0 |
| Ares Management LLC | 1.09M | ▲ 541.77K |
| Invesco Ltd. | 994.50K | ▼ 5.82K |
| Ubs Group AG | 753.74K | ▲ 251.99K |
| Rivernorth Capital Management, LLC | 702.80K | ▲ 702.80K |
| Beach Point Capital Management LP | 515.89K | ▲ 479.07K |
| North Ground Capital | 500.00K | ▼ 20.80K |
| Mariner, LLC | 471.85K | ▲ 30.73K |
| Bulldog Investors, Llp | 437.18K | ▼ 19.78K |
Held by 18 ETFs
Biggest fund positions in CCAP by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 26 | Breaux Jason | buy | 5,000 |
| Nov 16, 26 | Lombard Gerhard | buy | 2,000 |
| Sep 8, 26 | FIDELITY & GUARANTY LIFE INSURANCE CO | sell | 126,436 |
| Sep 9, 26 | FIDELITY & GUARANTY LIFE INSURANCE CO | sell | 139,054 |
| Sep 3, 26 | FIDELITY & GUARANTY LIFE INSURANCE CO | sell | 5,011 |
| Sep 4, 26 | FIDELITY & GUARANTY LIFE INSURANCE CO | sell | 10,471 |
| Sep 1, 26 | FIDELITY & GUARANTY LIFE INSURANCE CO | sell | 11,285 |
| Sep 2, 26 | FIDELITY & GUARANTY LIFE INSURANCE CO | sell | 45,000 |
| Aug 28, 26 | FIDELITY & GUARANTY LIFE INSURANCE CO | sell | 15,000 |
| Aug 31, 26 | FIDELITY & GUARANTY LIFE INSURANCE CO | sell | 40,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CCAP coverage
Recent articles, reports, and earnings notes.
No research on CCAP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CCAP report →The Roth IRA Mistake That Turns a 59-Year-Old’s $6,325 a Month in Tax-Free Dividends Into a Tax Bill
247wallst.com · Nov 20
Crescent Capital: Medium-Quality BDC With 2 Catalysts For Growth
seekingalpha.com · Nov 18
Crescent Capital: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 10
Crescent Capital BDC, Inc. (CCAP) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 10
What Crescent Capital BDC (CCAP) Said on Its Q3 Earnings Call
marketbeat.com · Nov 10
Wall Street Analysts Believe Crescent Capital BDC (CCAP) Could Rally 34.31%: Here's is How to Trade
zacks.com · Nov 10
Crescent Capital BDC (CCAP) Surpasses Q3 Earnings and Revenue Estimates
zacks.com · Nov 9
Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program
globenewswire.com · Nov 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.